Every year, MIT Technology Review puts out a list of people under 35 who are doing really cool stuff with technology. It’s called the 35 Innovators Under 35, and it’s a big deal. These are the folks ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are ...

Nanopore sensors enable precise protein and peptide analysis, crucial for early disease diagnosis and advancing personalized healthcare solutions.

Breakthrough Innovations Drive Expansion of the Global Infectious Disease Diagnostics MarketThe Global Infectious Disease ...

The global Early-Stage Lung Cancer Diagnostics Therapy Market is entering a transformative decade. With its valuation ...

The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...

Biomarkers are pivotal for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities. Recent ...

As costs for diagnostic and sequencing technologies have plummeted in recent years, researchers have collected an unprecedented amount of data around ...

Interestingly, while only 16% of oncology researchers reported using AI in biomarker detection and assessment at the time of ...

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.

Deep inside the body, a silent and slow-growing problem can start. In about 1 in 5 older adults, a small group of mutated ...